source
- MimiVax's glioblastoma vaccine falls short of Phase 2b primary endpointMimiVax reported that its investigational vaccine for glioblastoma did not achieve the primary efficacy goal in a Phase 2b trial. The study, more than a decade in development, compared the vaccine…
- Executive candidates need full truth, not a sales pitch, to address company challengesThe article argues that candidates for senior roles must be given an honest picture of the company's problems rather than a polished sales narrative. It notes that during executive searches, infor…